GTS Securities’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding VIGL
GTS Securities's VIGL Position: Q3 2025 in Review
GTS Securities sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 25,000 shares — an estimated $199K sold.
GTS Securities first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $199K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.
- GTS Securities reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
- GTS Securities sold 25,000 Vigil Neuroscience shares in Q3 2025, an estimated $199K.
- GTS Securities first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
- GTS Securities's Vigil Neuroscience position peaked at $199K in Q2 2025.
- 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.
Based on GTS Securities's 13F filing for Q3 2025, filed 14 Nov 2025.